The CANM is “the voice” for nuclear medicine specialists in Canada and solely represents the interests of our specialists. Over the past years, the CANM has been active in promoting and defending the needs of Canadian nuclear medicine specialists, especially during the medical isotope crisis. It is only through your active support that we are able to continue with multiple endeavours at both the provincial and federal levels.
Being a member of the Canadian Association of Nuclear Medicine offers you growth and continuing education that you won't find anywhere else, along with the resources and connections to help your career flourish in the imaging community. CANM offers a wealth of benefits for its members.
CANM is committed to providing information to the medical, patient advocacy, scientific, regulatory, legislative and funding communities to ensure that the value of nuclear medicine and molecular imaging is understood. The support of these communities will help us ensure that the technologies are used in the right patient at the right time.
CANM has created a multi-faceted outreach program that utilizes a variety of tools and methods to reach the imaging community, referring physicians, patient and consumer groups, and regulators and legislators.
CANM has enhanced existing relationships and developed new partnerships with relevant societies and patient organizations. We continue to pursue opportunities to create collaborations for educational activities, such as symposia, webinars on key topics of interest, podcasts on key issues, educational materials, and joint sessions.
The Canadian Association of Nuclear Medicine has established awards to recognize and support, nuclear medicine specialists, residents and medical students.
The CANM offers activities to help meet your educational needs and to obtain accredited CPD hours.
CANM is reaching out to similar organizations, such as the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine (SNM) and the World Federation of Nuclear Medicine and Biology (WFNMB).
Molecular imaging procedures—which are noninvasive, safe and painless—are used to diagnose and manage the treatment of cancer, heart disease, brain disorders such as Alzheimer’s and Parkinson’s disease, gastrointestinal disorders, lung disorders, bone disorders, kidney and thyroid disorders, and more.
The Canadian Association of Nuclear Medicine Membership Directory for members use only.
Document prepared by
Document prepared by Jean-Luc Urbain, MD, PhD, Andrew Ross, MD,Patrick Martineau, MD, PhD., Amit Singnurkar, MDCM, MPH, MBA,Philip Cohen, MD, Kalevi Kairemo, MD, PhD
The aim of this document is to provide theCanadian medical community with background information on and an illustration of the current status of prostate cancer imaging with Prostate SpecificMembrane Antigen (PSMA) PET/CT imaging. It does not represent policy guidelines from the Canadian Association of Nuclear Medicine (CANM) nor is it intended to duplicate, contradict or replacePSMA guidelines published by other societies/associations/organizations such as the Society of Nuclear Medicine &Molecular Imaging (SNMMI), the EuropeanAssociation of Nuclear Medicine (EANM),urological societies, governmental or non governmental entities.
Document prepared by
Phill F Cohen md FRCP(c) ABNM, Robert Tarzwell, MD, FRCPC, Leonard Numerow MD FRCP(C), Yin-Hui Siow, MD, FRCPC, John M Uszler, MD, MS, Dan G. Pavel, MD (Deceased), Sonia Neubauer, MD, Joe Cardacci MBBS, FAANMS, FRACP, Manu Mehdiratta MD FRCP(C), Behzad Mansouri MD PhD FRCP(C), Theodore A Henderson MD PhD, John F. Rossiter-Thornton, MB, FRCPC, Muriel J. van Lierop, MBBS, MD PAC(M), Mary McLean MBChB, FRCP(C), Zohar Waisman MD, FRCP (C), Simon W. DeBruin, MSEE, Dr. John W. Baird, James McLean, MS, P.Eng., Mina Bechai, Hayley Wagman, BSc, Alexi T Gosset.
Document prepared by
Jean-Luc Urbain, MD, PhD, Jonathan Richardson, CNMT, Andrew Ross, MD, Mehdi Khider, MD, Cigdem Akincioglu, MD
